Exelan Pharmaceuticals Inc.
Industry
- Pharmaceuticals
- Generic Drugs
Latest on Exelan Pharmaceuticals Inc.
The coronavirus pandemic may have put the spotlight on supply chain risks but it has also nudged front-line drug firms in India like Cipla Limited towards “reimagining” other aspects of their operat
A decade is a long time in a company’s life – one that could be potentially transformational in terms of strategy, direction and growth. And leadership in the corner office typically shapes much of th
InvaGen Pharmaceuticals Inc. , a subsidiary of Cipla Ltd. , is acquiring the Nasdaq-listed Avenue Therapeutics Inc. , with an eye on its late-stage asset, intravenous (IV) tramadol, which could addr
Cipla Ltd. , which has in the past admitted its smaller presence in the US compared with some Indian peers may be weighing down its earnings, expects to take its North American business to a “meaning